Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

FDA Clears InfraReDx Coronary Imaging System

BioPhotonics
Jun 2008
The FDA has granted 510(k) clearance to InfraReDx Inc. of Burlington, Mass., to market its catheter-based LipiScan coronary imaging system. The device uses near-infrared spectroscopy to identify lipid-core-containing plaques in the coronary arteries of patients undergoing cardiac catheterization. These plaques, which cannot be detected by commonly used tests, are suspected of causing sudden cardiac deaths and nonfatal heart attacks.

Biophotonicscoronary arteriesInfraReDx Inc.LipiScan coronary imaging systemNews & Featuresspectroscopy

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.